PURPOSE: Tricuspid regurgitation contributes to right ventricular failure (RVF) and is associated with worse clinical outcomes in patients undergoing left ventricular assist device (LVAD) treatment. However, whether tricuspid valve repair (TVR) at the time of LVAD implantation improves outcomes is not clear. METHODS: We identified all patients undergoing initial implantation of a long-term continuous-flow LVAD at our institution from March 2006 to August 2011. We assessed the impact of TVR on survival and incidence of RVF using Kaplan-Meier curves and proportional hazards regression adjusted for age, gender, baseline tricuspid regurgitation, RV function, MELD score, albumin, and indication (bridge vs. destination). RESULTS: A total of 101 patients were included in the analysis, of which 14 patients underwent TVR concomitant LVAD. All TVR patients had moderate or severe baseline regurgitation. Crude survival was not different between groups. In multivariable models adjusted for confounding factors, TVR showed a significant association with improved survival (HR = 0.1, p = 0.049). Adjusted models showed no difference in RVF. CONCLUSIONS: In this cohort of patients, TVR at the time of LVAD implantation appears associated with better survival. Additional larger studies are needed to verify the effect of TVR at the time of LVAD implantation, and whether it should be utilized more frequently.
PURPOSE:Tricuspid regurgitation contributes to right ventricular failure (RVF) and is associated with worse clinical outcomes in patients undergoing left ventricular assist device (LVAD) treatment. However, whether tricuspid valve repair (TVR) at the time of LVAD implantation improves outcomes is not clear. METHODS: We identified all patients undergoing initial implantation of a long-term continuous-flow LVAD at our institution from March 2006 to August 2011. We assessed the impact of TVR on survival and incidence of RVF using Kaplan-Meier curves and proportional hazards regression adjusted for age, gender, baseline tricuspid regurgitation, RV function, MELD score, albumin, and indication (bridge vs. destination). RESULTS: A total of 101 patients were included in the analysis, of which 14 patients underwent TVR concomitant LVAD. All TVRpatients had moderate or severe baseline regurgitation. Crude survival was not different between groups. In multivariable models adjusted for confounding factors, TVR showed a significant association with improved survival (HR = 0.1, p = 0.049). Adjusted models showed no difference in RVF. CONCLUSIONS: In this cohort of patients, TVR at the time of LVAD implantation appears associated with better survival. Additional larger studies are needed to verify the effect of TVR at the time of LVAD implantation, and whether it should be utilized more frequently.
Authors: Valentino Piacentino; Constantine D Troupes; Asvin M Ganapathi; Laura J Blue; G Burkhard Mackensen; Madhav Swaminathan; G Michael Felker; Mark Stafford-Smith; Andrew J Lodge; Joseph G Rogers; Carmelo A Milano Journal: Ann Thorac Surg Date: 2011-10 Impact factor: 4.330
Authors: Valentino Piacentino; Asvin M Ganapathi; Mark Stafford-Smith; Michael K Hsieh; Chetan B Patel; Alan A Simeone; Joseph G Rogers; Carmelo A Milano Journal: J Thorac Cardiovasc Surg Date: 2012-08-29 Impact factor: 5.209
Authors: Valentino Piacentino; Matthew L Williams; Tim Depp; Karla Garcia-Huerta; Laura Blue; Andrew J Lodge; G Burkhard Mackensen; Madhav Swaminathan; Joseph G Rogers; Carmelo A Milano Journal: Ann Thorac Surg Date: 2011-04-01 Impact factor: 4.330
Authors: Diyar Saeed; Trilokesh Kidambi; Shanaz Shalli; Brittany Lapin; S Chris Malaisrie; Richard Lee; William G Cotts; Edwin C McGee Journal: J Heart Lung Transplant Date: 2011-01-06 Impact factor: 10.247
Authors: Robert L Kormos; Jeffrey J Teuteberg; Francis D Pagani; Stuart D Russell; Ranjit John; Leslie W Miller; Todd Massey; Carmelo A Milano; Nader Moazami; Kartik S Sundareswaran; David J Farrar Journal: J Thorac Cardiovasc Surg Date: 2010-02-04 Impact factor: 5.209
Authors: Marian Kukucka; Alexander Stepanenko; Evgenij Potapov; Thomas Krabatsch; Hermann Kuppe; Helmut Habazettl Journal: J Heart Lung Transplant Date: 2012-09 Impact factor: 10.247
Authors: Jay D Pal; Charles T Klodell; Ranjit John; Francis D Pagani; Joseph G Rogers; David J Farrar; Carmelo A Milano Journal: Circulation Date: 2009-09-15 Impact factor: 29.690
Authors: Salil V Deo; Tal Hasin; Salah E Altarabsheh; Stephen H McKellar; Ishan K Shah; Lucian Durham; John M Stulak; Richard C Daly; Soon J Park; Lyle D Joyce Journal: J Card Surg Date: 2012-11 Impact factor: 1.620
Authors: Konstantin Zhigalov; Marcin Szczechowicz; Ahmed Mashhour; Bakitbek K Kadyraliev; Sabreen Mkalaluh; Jerry Easo; Juergen Ennker; Harald C Eichstaedt; Alexander Weymann Journal: J Thorac Dis Date: 2019-04 Impact factor: 2.895
Authors: Julia Riebandt; Anne Schaefer; Dominik Wiedemann; Thomas Schlöglhofer; Günther Laufer; Sigrid Sandner; Daniel Zimpfer Journal: Ann Cardiothorac Surg Date: 2021-03
Authors: Evgenij V Potapov; Christiaan Antonides; Maria G Crespo-Leiro; Alain Combes; Gloria Färber; Margaret M Hannan; Marian Kukucka; Nicolaas de Jonge; Antonio Loforte; Lars H Lund; Paul Mohacsi; Michiel Morshuis; Ivan Netuka; Mustafa Özbaran; Federico Pappalardo; Anna Mara Scandroglio; Martin Schweiger; Steven Tsui; Daniel Zimpfer; Finn Gustafsson Journal: Eur J Cardiothorac Surg Date: 2019-08-01 Impact factor: 4.191
Authors: Claudio J R Gomez Hamacher; Carolin Torregroza; Najla Sadat; Daniel Scheiber; Jil-Cathrin von der Beek; Ralf Westenfeld; Ivonne Jeanette Knorr; Martin Sager; Artur Lichtenberg; Diyar Saeed Journal: JTCVS Open Date: 2020-09-24